Additionally, estrogen may attenuate the severity of ARDS in COVID‐19 by reducing ACE2‐dependent NOX2 activation, reactive oxygen species production, and endothelial inflammation [34]. Here, ACE2 is linked to acute respiratory distress syndrome.